Hi Sanjee,
This topic is certainly relevant to our community. ARv7 is a traditional target that presents significant challenges in reagent generation and ligandability. Developing a degrader approach for this target is quite difficult. Would you be willing to share your insights in a forum post, or would you prefer to present them at one of our Science Circle Meetings?
Best wishes,
Markus
------------------------------
Markus Queisser
Scientific Director
GlaxoSmithKline
Stevenage
441438764034
------------------------------